Laevofolinic acid, 5-fluorouracil, cyclophosphamide and escalating doses of epirubicin with granulocyte colony-stimulating factor support in locally advanced and/or metastatic breast carcinoma: a phase I-II study of the Southern Italy Oncology Group (GOIM).

Sixty-four consecutive patients with locally advanced (n = 7) or metastatic breast cancer (n = 57), were treated with a combination of laevofolinic acid 100 mg m-2 plus 5-fluorouracil 340 mg m-2 i.v. on days 1-3, cyclophosphamide 600 mg m-2 i.v. on day 1 and epirubicin 90 mg m-2 i.v. on day 1. Epiru...

Descripción completa

Detalles Bibliográficos
Autores principales: Colucci, G., Romito, S., Gebbia, V., Pacilio, G., Giotta, F., Testa, A., Pezzella, G., Durini, E., Agostara, B., Cariello, S.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1995
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033921/
https://www.ncbi.nlm.nih.gov/pubmed/7577476

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033921/
https://www.ncbi.nlm.nih.gov/pubmed/7577476

Ejemplares similares